Beyond Novo and Eli Lilly, companies such as Boehringer Ingelhium, Pfizer, Roche, AstraZeneca, Regor therapeutics, Viking Therapeutics, Amgen, BioAge Labs, Gan & Lee Pharmaceuticals, Sun Pharma, Innovent Biologics, Aphaia Pharma, Vertex Pharmaceuticals , and others are entering the space, fueling new innovations in GLP-1 therapies, combination therapies, and next-gen metabolic treatments
Hair follicles are metabolically active but not essential for survival
This observation sparked interest in developing medications that could boost incretin activity, potentially treating both diabetes and obesity
Users may experience mild to moderate discomfort at injection sites due to copper peptide irritation
Jan 2020;48(October 2019):102246
The focus should be on restoring balance, not creating excess, Knight says